Angiotensin-converting enzyme and lipoprotein (a) as risk factors for myocardial infarction
Haber, E.
Circulation 91(6): 1888-1890
1995
ISSN/ISBN: 0009-7322 PMID: 7882501 Document Number: 441694
Document emailed within 1 workday
Related Documents
Pulla Reddy, B.; Srikanth Babu, B.M.; Venkata Karunakar, K.; Yasovanthi, J.; Munshi, A.; Sampath Kumar, P.; Sharath, A.; Jyothy, A. 2010: Angiotensin-converting enzyme gene variant and its levels: risk factors for myocardial infarction in a South Indian population Singapore Medical Journal 51(7): 576-581Kobayashi, T.; Miyauchi, T.; Sakai, S.; Yamaguchi, I.; Goto, K.; Sugishita, Y. 1998: Endothelin-converting enzyme and angiotensin-converting enzyme in failing hearts of rats with myocardial infarction Journal of Cardiovascular Pharmacology 31(Suppl): S417-S420
Papadopoulos, D.P.; Economou, E.V.; Makris, T.K.; Kapetanios, K.J.; Moyssakis, I.; Votteas, V.E.; Toutouzas, P.K. 2004: Effect of angiotensin-converting enzyme inhibitor on collagenolytic enzyme activity in patients with acute myocardial infarction Drugs under Experimental and Clinical Research 30(2): 55-65
Renkin, J. 1996: Clinical benefit of angiotensin converting enzyme inhibition after acute myocardial infarction: myocardial reperfusion revisited Journal of Hypertension. Supplement: Official Journal of the International Society of Hypertension 14(6): S15-S19
Huckell, V.F.; Bernstein, V.; Cairns, J.A.; Crowell, R.; Dagenais, G.R.; Higginson, L.A.; Isserow, S.; Laramée, P.; Liu, P.; McCans, J.L.; Orchard, R.C.; Prewitt, R.; Quinn, B.P.; Samson, M.; Turazza, F.; Warnica, J.W.; Wielgosz, A. 1997: Angiotensin-converting enzyme inhibition in myocardial infarction--Part 1: Clinical data Canadian Journal of Cardiology 13(2): 161-169
Pfeffer, M.A. 1991: Angiotensin converting enzyme inhibition therapy following myocardial infarction. Rationale for clinical trials Herz 16 Spec No 1: 278-282
Ludwig, E.; Corneli, P.S.; Anderson, J.L.; Marshall, H.W.; Lalouel, J.M.; Ward, R.H. 1995: Angiotensin-converting enzyme gene polymorphism is associated with myocardial infarction but not with development of coronary stenosis Circulation 91(8): 2120-2124
Preobrazhenskiĭ, D.V.; Sidorenko, B.A.; Pershukov, I.V.; Batyraliev, T.A.; Pataraia, S.A. 2006: Angiotensin converting enzyme inhibitors in acute period of myocardial infarction: the place of zofenopril Kardiologiia 46(5): 89-95
Sobstyl, J.; Dzida, G.; Puźniak, A.; Mosiewicz, J.; Hanzlik, J. 2002: Angiotensin-converting enzyme gene insertion/deletion polymorphism in Polish patients with myocardial infarction Annales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina 57(2): 21-28
Jeremic, G.; Masson, S.; Luvara, G.; Porzio, S.; Lagrasta, C.; Riva, E.; Olivetti, G.; Latini, R. 1996: Effects of a new angiotensin-converting enzyme inhibitor (idrapril) in rats with left ventricular dysfunction after myocardial infarction Journal of Cardiovascular Pharmacology 27(3): 347-354
Bakaev, R.G.; Strutynskiĭ, A.V.; Kallaeva, A.N.; Glazunov, A.B.; Voronina, M.A.; Pekhtereva, D.A.; Moshkova, N.K.; Chudnovskaia, E.A.; Kochetkov, B.M. 2011: Effects of long-term therapy with angiotensin-converting enzyme inhibitor and carvedilol on the heart remodeling process after non-Q-wave myocardial infarction Klinicheskaia Meditsina 89(1): 23-26
Sharma, P.; Carter, N.D.; Barley, J.; Brown, M.M. 1994: Molecular approach to assessing the genetic risk of cerebral infarction: deletion polymorphism in the gene encoding angiotensin 1-converting enzyme Journal of Human Hypertension 8(8): 645-648
Bennouar, N.; Allami, A.; Laraqui, A.; Azeddoug, H.; El-Kadiri, N.; Benkouka, F.; Bendriss, A.; Ghannam, R.; Benomar, A.; Fellat, S.; Benomar, M. 2004: Apolipoprotein E and angiotensin-converting enzyme gene polymorphisms as risk factors of coronary disease Annales de Biologie Clinique 62(3): 295-304
Tereshchenko, S.N.; Dzhaiani, N.A.; Moiseev, V.S.; Nosikov, V.V. 2002: Effect of perindopril on left ventricular structural and functional parameters in patients with preserved systolic function after myocardial infarction. Relation to polymorphism of angiotensin converting enzyme gene Kardiologiia 42(5): 38-41
Zhou, H.; Bian, Y-fei.; Li, M-lian.; Gao, F.; Xiao, C-shi. 2010: Effects of RNA interference targeting angiotensin 1 receptor and angiotensin-converting enzyme on blood pressure and myocardial remodeling in spontaneous hypertensive rats Zhonghua Xin Xue Guan Bing Za Zhi 38(1): 60-66
Keavney, B.; McKenzie, C.; Parish, S.; Palmer, A.; Clark, S.; Youngman, L.; Delépine, M.; Lathrop, M.; Peto, R.; Collins, R. 2000: Large-scale test of hypothesised associations between the angiotensin-converting-enzyme insertion/deletion polymorphism and myocardial infarction in about 5000 cases and 6000 controls. International Studies of Infarct Survival (ISIS) Collaborators Lancet 355(9202): 434-442
Vijan, S.G. 2009: Angiotensin-converting enzyme inhibitors (ACEIs), not angiotensin receptor blockers (ARBs), are preferred and effective mode of therapy in high cardiovascular risk patients Journal of the Indian Medical Association 107(3): 178-182
Sharma, P.; Carter, N.D.; Barley, J.; Lunt, R.; Seymour, C.A.; Brown, M.M. 1994: Polymorphisms in the gene encoding angiotensin 1-converting enzyme and relationship to its post-translational product in cerebral infarction Journal of Human Hypertension 8(8): 633-634
Arnaout, M.S.; Khalil, A.; Alam, S.E. 2003: Influence of angiotensin converting enzyme inhibitors on stable myocardial ischemia in menopausal cardiac patients Clinical and Experimental Obstetrics and Gynecology 30(1): 43-46
Muller, C.A.; Opie, L.H.; Peisach, M.; Pineda, C.A. 1992: Antiarrhythmic effects of the angiotensin converting enzyme inhibitor perindoprilat in a pig model of acute regional myocardial ischemia Journal of Cardiovascular Pharmacology 19(5): 748-754